title: Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant.
abstract: The management of acute leukaemia which relapses following an allogeneic stem cell transplant remains a major challenge. In this review we summarize the outcomes of the currently available treatment modalities and discuss emerging novel approaches.
authors.affiliation: Section of Haemato-Oncology, Royal Marsden Hospital, Surrey, UK. bshaw@doctors.org.uk
authors.forename: B E
authors.initials: BE
authors.lastname: Shaw
authors.forename: N H
authors.initials: NH
authors.lastname: Russell
mesh_terms: D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D016219:Immunotherapy, Adoptive; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D018365:Neoplasm, Residual; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D012008:Recurrence; D014184:Transplantation, Homologous
chemical_list: D047428:Protein Kinase Inhibitors